We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImage Scan Holdings Regulatory News (IGE)

Share Price Information for Image Scan Holdings (IGE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.20
Bid: 1.10
Ask: 1.30
Change: 0.00 (0.00%)
Spread: 0.20 (18.182%)
Open: 1.20
High: 1.20
Low: 1.20
Prev. Close: 1.20
IGE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

25 Apr 2019 07:00

RNS Number : 9948W
Image Scan Holdings PLC
25 April 2019
 

25/04/2019

Image Scan Holdings plc

("Image Scan" or the "Company")

(AIM: IGE)

 

Interim Results

 

First half performance behind management expectations but guidance maintained for full year

 

Image Scan, (AIM: IGE) specialists in the field of X-ray imaging for the security and industrial inspection markets today announces its interim results for the six months ended 31 March 2019. Whilst the performance during the first six months was slightly behind expectations, the Board expects to meet market expectations for the year to 30 September 2019.

Financial summary:

· Order intake steady at £2.1m (2018: £2.0m)

· Revenue declined to £1.4m (2018: £2.0m)

· Gross profit margin increased to 47% (2018: 42%)

· Loss before taxation of £178k (2018: profit of £39k)

· Period end bank balance of £750k (2018: £752k)

· Period end order book of £1.0m (2018: £1.1m)

· Expected to meet market expectations for the financial year end

 

Operational highlights:

· Renewed focus on organic growth with investment in marketing and product development

· Orders for portable X-ray units up 14% on the prior period

· Tightening emissions control legislation in India and China supports industrial unit sales

· Over 90% of industrial units now under long term service contract

· Aftermarket sales strategy developed, offering significant upgrades to existing portable X-ray users

· New product development programme is underway targeted at new product sector

· Sales behind management expectations at the end of H1 due to contract delays with International Government customers but are expected to recover during H2

Bill Mawer, Chairman and Chief Executive Officer of Image Scan, commented: "The recent decline in the share price is clearly disappointing for all shareholders. Our short-term strategy is a simple one: to take more of our X-ray inspection systems, to more markets, as fast as possible. The entire staff of the Company is focused to this activity. We start the second half with a £1.0m order book and sufficient activity in our pipeline for the Board to expect the Company to meet market expectations for the year to 30 September 2019."

 

For further information on the Company, please visit: www.ish.co.uk and for further information on its products, please visit: www.3dx-ray.com

 

 

Enquiries:

 

Image Scan Holdings plc

William Mawer, Chairman and Chief Executive Officer

Sarah Atwell King, Company Secretary

Tel: +44 (0) 1509 817 400

ir@ish.co.uk

Cantor Fitzgerald Europe

Rick Thompson / Will Goode (Corporate Finance)

Caspar Shand Kydd (Sales)

Tel: +44 (0) 207 894 7000

 

Chairman's statement

 

Introduction

Image Scan Holdings plc is a specialist in innovative X-ray technology, operating globally in the security and industrial inspection sectors. The Company's principal activity is the design, manufacture and supply of both portable and fixed X-ray security screening systems to governments, security organisations and law enforcement agencies. The Company also supplies high-quality image acquisition systems for non-destructive testing to commercial organisations worldwide.

 

Financial results

New order intake was steady at £2.1m, though that figure includes an increase in orders received for portable X-ray systems of 14% over the equivalent period in the prior year.

 

Revenues for the six months ended 31 March 2019 were £1.4m, (2018: £2.0) which included an order for 20 portable security units delivered to a South East Asian customer close to the period end. Gross margin was increased to 47% (2018:42%) reflecting good margins on security orders.

 

Overhead costs increased to £854k (2018: £793k) and included an increase in R&D spend across a number of key projects. The business made a pre-tax loss of £178k (2018: profit of £39k).

 

The Company finished the period with an order book of £1.0m (2018: £1.1m) and a cash balance of £750k (2018: £752k)

 

 

Overview

 

While it is good to see portable X-ray orders increase over the prior period, we recognise that we still have some way to go to reach the record levels recorded in FY17. Key security customers in the period were in South East Asia while shows were attended and demonstrations carried out in South America, Asia and Europe. The business is fully focussed on getting its product to market and has an extensive programme of customer demonstrations and trials organised over the coming months.

 

Revenues were behind management expectations at the end of the period, reflecting the unpredictable nature of Government procurement processes. However, with customer decisions due on several key projects, activity is expected to increase in the second half.

 

A number of initiatives are underway to further increase security sales. These including an upgrade programme for existing ThreatScan®LS1 users, including panel and communications upgrades and the ability to use X-ray film with the system.

 

 

The Company has launched a new development project, based on our existing technologies, that will produce a new X-ray security system that will be taken to market through our existing network of international partners. A prototype should be available by the end of 2019.

 

In the industrial area, the period has seen deployments of multiple systems to both India and China, as our major customers respond to demand driven by tighter emissions control regulations in those countries. We finish the period with three further units in the order book and being manufactured for delivery in H2. We have over 90% of all industrial systems in the field under valuable service and support contracts.

 

 

Outlook

 

The Company continues to see strong demand in both its significant product ranges. In security, there is a good pipeline of opportunities and the team is working hard to convert these into orders. We continue to expand the market footprint and frequently add new partners to our network. In industrial, our major customers are selectively building capacity in regions where tighter emissions control legislation, particularly for diesel engines, is driving demand, and this should continue to yield orders for our inspections systems. The addition of new industrial systems to our service scheme will provide additional recurring income.

 

In order to drive short to medium growth for the business we are now developing new X-ray inspection systems and have a pipeline of such projects. We expect to start seeing revenue from the first of these projects in the next financial year.

 

The staff at Image Scan continue to be enthusiastic, dedicated and creative and on behalf of my fellow Board members, I would like to formally thank our staff for their contribution during this period.

 

The Board and staff of Image Scan look forward to the future with confidence.

 

Bill Mawer

Chairman and Chief Executive Officer

25/04/2019

 

 

 

Consolidated income statement

For the six months ended 31 March 2019

 

 

Note

Six months

ended

31 March 2019

(Unaudited)

£'000

Six months

ended

31 March 2018

(Unaudited)

£'000

Year ended

30 September

 2018

(Audited)

£'000

Revenue

 

1,423

1,990

3,465

Cost of sales

 

(747)

(1,158)

(1,820)

Gross profit

 

676

832

1,645

Other operating income

 

-

-

48

Operating expenses

 

(854)

(793)

(1,597)

Exceptional Items

 

-

-

(251)

Operating profit

 

(178)

39

(155)

Finance income

 

-

-

-

Profit before taxation

 

(178)

39

(155)

Taxation

 

-

-

(65)

(Loss0/profit for the period

 

(178)

39

(200)

 

 

 

Pence

Pence

Pence

Earnings per share

 

 

 

 

Basic profit per share

[3]

(0.13)

0.03

(0.16)

Diluted profit per share

 

(0.13)

0.03

(0.16)

 

 

Consolidated statement of changes in equity

For the six months ended 31 March 2019

 

 

Note

Six months

ended

31 March 2019

(Unaudited)

£'000

Six months

ended

31 March 2018

(Unaudited)

£'000

Year ended

30 September

 2018

(Audited)

£'000

Opening equity shareholders' funds

 

1,630

1,821

1,821

Shares issued in the year

 

-

6

17

Share-based payments

[4]

3

6

12

(Loss)/Profit attributable to equity shareholders

 

(178)

39

(220)

Closing equity shareholders' funds

 

1,455

1,872

1,630

 

 

Consolidated statement of financial position

As at 31 March 2019

 

 

As at

31 March 2019

(Unaudited)

£'000

As at

31 March 2018

(Unaudited)

£'000

As at

30 September

 2018

(Audited)

£'000

Non-current assets

 

 

 

Plant and equipment

86

20

71

 

86

20

71

Current assets

 

 

 

Inventories

804

676

939

Trade and other receivables

499

1,327

783

Cash and cash equivalents

750

752

782

 

2,053

2,755

2,504

Total assets

2,139

2,775

2,575

Current liabilities

 

 

 

Trade and other payables

646

855

910

Non-current liabilities

 

 

 

Provisions for liabilities and charges

38

48

35

Total liabilities

684

903

945

Net assets

1,455

1,872

1,630

Equity

 

 

 

Share capital

1,363

1,360

1,363

Share premium account

8.328

8,320

8,328

Retained earnings

(8,236)

(7,808)

(8,061)

Equity shareholders' funds

1,455

1,872

1,630

 

 

Consolidated cash flow statement

For the six months ended 31 March 2019

 

 

Six months

ended

31 March 2019

(Unaudited)

£'000

Six months

ended

31 March 2018

(Unaudited)

£'000

Year ended

30 September

 2018

(Audited)

£'000

Cash flows from operating activities

 

 

 

Operating (loss)/profit

(178)

39

(155)

Adjustments for:

 

 

 

Depreciation

12

7

16

Impairment of inventories

19

24

43

Increase/(decrease) in provision for warranty

3

-

(12)

Decrease in inventories

115

394

113

Decrease in trade and other receivables

237

267

774

(Decrease) in trade and other payables

(264)

(1,274)

(1,256)

Share-based payment charge

3

6

12

Net cash used in operating activities

(53)

(537

(465)

Corporation tax recovered

47

(30)

-

Net cash outflow from operating activities

(6)

(507)

(465)

 

 

 

 

Cash flows from investing activities

 

 

 

Purchase of property, plant and equipment

(26)

-

(23)

Net cash used in investing activities

(26)

-

(23)

 

 

 

 

Cash flows from financing activities

 

 

 

Proceeds from issue of share capital

-

6

17

Net cash from financing activities

-

6

17

 

 

 

 

Net (decrease)/increase in cash and cash equivalents

(32)

(501)

(471)

Cash and cash equivalents at beginning of period

782

1,253

1,253

Cash and cash equivalents at end of period

750

752

782

 

 

Notes to the unaudited interim financial statements

For the six months ended 31 March 2019

 

1 Basis of preparation

The interim financial statements, which are unaudited, have been prepared on the basis of the accounting policies expected to apply for the financial year to 30 September 2019 and in accordance with recognition and measurement principles of International Financial Reporting Standards ('IFRSs') as endorsed by the European Union. The accounting policies applied in the preparation of these interim financial statements are consistent with those used in the financial statements for the year ended 30 September 2018.

 

The interim financial statements do not include all of the information required for full annual financial statements and do not comply with all the disclosures in IAS 34 'Interim financial reporting'. Accordingly, whilst the interim statements have been prepared in accordance with IFRSs, they cannot be construed as being in full compliance with IFRSs.

 

The financial information for the year ended 30 September 2018 does not constitute the full statutory accounts for that period. The annual report and financial statements for the year ended 30 September 2018 have been filed with the Registrar of Companies. The Independent auditor's report on the report and financial statements for the year ended 30 September 2018 was unqualified, did not draw attention to any matters by way of emphasis, and did not contain a statement under Section 498(2) or 498(3) of the Companies Act 2006.

 

2 Going concern

The interim financial information has been prepared on a going concern basis, which assumes that the Company will have adequate resources to continue in operational existence for the foreseeable future.

 

3 Earnings per share ('EPS')

Basic earnings per ordinary share is based on the loss on ordinary activities before taxation of £177,841 and on 136,354,577 ordinary shares in issue throughout the period.

 

Diluted profit per share is calculated by adjusting the weighted average number of ordinary shares in issue on the assumption of conversion of dilutive potential ordinary shares, based on the share price at the end of the period. The Company's dilutive potential ordinary shares are shares issued under the Company's Enterprise Management Incentive ('EMI') scheme and options issued under the Company's Unapproved scheme.

 

4 IFRS 2 'Share-based payments'

Operating expenses includes a charge of £2,777 (2018: £5,887) after valuation of the Company's employee share option schemes in accordance with IFRS 2. Under this standard, the fair value of the options at the grant date is spread over the vesting period. These charges have been credited to equity in accordance with IFRS2 as presented in the consolidated statement of changes in equity.

 

5 Additional copies

Further copies of the 2019 interim report are available on the Company's website, www.ish.co.uk, and from the Company's registered office, 16-18 Hayhill Industrial Estate, Sileby Road, Barrow-upon-Soar, Leicestershire LE12 8LD.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR LLFVSSTISFIA
Date   Source Headline
12th Mar 20247:00 amRNSLaunch of AXIS-CXi Cabinet with AI Software
28th Feb 20242:48 pmRNSResult of AGM
28th Feb 20247:00 amRNSTrading Statement
26th Jan 20241:50 pmRNSHolding(s) in Company
18th Jan 20241:28 pmRNSHolding(s) in Company
11th Jan 20243:06 pmRNSHolding(s) in Company
9th Jan 202412:46 pmRNSNotice of AGM & Posting of Annual Report
9th Jan 202412:00 pmRNSHolding(s) in Company
22nd Dec 20231:30 pmRNSHolding(s) in Company
12th Dec 20237:00 amRNSFinal Results
10th Oct 20237:00 amRNSTrading Update
11th Sep 20237:00 amRNS2023 orders to over 30 countries
4th Jul 20237:00 amRNSHolding(s) in Company
26th Apr 20237:00 amRNSInterim Results
13th Mar 20239:34 amRNSHolding(s) in Company
28th Feb 20233:03 pmRNSResult of AGM
28th Feb 20237:00 amRNSTrading Statement
10th Feb 20231:26 pmRNSHolding(s) in Company
26th Jan 202312:09 pmRNSDirector/PDMR Shareholding
18th Jan 20238:52 amRNSPosting of annual report and notice of AGM
17th Jan 20233:23 pmRNSImage Scan makes first sale of new product
23rd Dec 202211:54 amRNSDirector/PDMR Shareholding
14th Dec 20224:14 pmRNSAppointment of Director
13th Dec 20224:25 pmRNSHolding(s) in Company
13th Dec 20227:00 amRNSFinal Results
9th Dec 20227:00 amRNSNotice of Results
6th Oct 20227:00 amRNSTrading Update
1st Aug 20224:10 pmRNSHolding(s) in Company
25th May 20227:00 amRNSBoard Changes
27th Apr 20227:00 amRNSInterim Results
3rd Mar 20227:00 amRNSNew Industrial Customer
22nd Feb 20223:03 pmRNSResult of AGM
22nd Feb 20227:00 amRNSTrading Statement
20th Jan 202211:53 amRNSPosting of Accounts & AGM Notice
12th Jan 20227:00 amRNSLaunch of new portable X-ray system
10th Dec 20219:05 amRNSInvestor Presentation
7th Dec 202110:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
7th Dec 20217:00 amRNSFinal Results
10th Nov 20211:16 pmRNSAppointed global distributor for Serstech AB
10th Nov 20217:00 amRNSPortable x-ray sale to US Federal Agency
3rd Nov 20217:00 amRNSPre-Close Trading Update
27th Oct 20219:32 amRNSDirector Declaration
13th Sep 20217:00 amRNSTrading Update – New Orders
17th Jun 20217:00 amRNSFirst portable X-Ray sale to Australia
28th Apr 202110:03 amRNSInterim Report - Replacement
28th Apr 20217:00 amRNSNew order
28th Apr 20217:00 amRNSInterim Report
23rd Feb 202111:18 amRNSResult of AGM
22nd Feb 20217:00 amRNSTrading Statement
15th Feb 202111:33 amRNSMello presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.